This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

New Study Finds 1 In 4 Think Their Families Resent Them For Having Diabetes

ARLINGTON, Va., March 20, 2013 /PRNewswire/ -- Four out of every ten people with diabetes say their families don't fully support their efforts to manage their diabetes, one in four resent them for having diabetes, and three in 10 think their families blame them for getting diabetes, according to a new survey conducted by HealthEngage among its users in the United States.

The national survey, which included type 1 and 2 diabetics, was specifically designed to collect information about how people with diabetes perceive the sentiments and attitudes of their family towards them. 

Additional insights include:

  • 57% of respondents say that their families don't make sacrifices in their lives to make it easier for them to manage their diabetes.
  • 50% of respondents believe that their families are afraid of their diagnosis.
  • 55% believe that their families are living a healthier life as a result of their diagnosis.
  • 30% say that their families join them in their exercise or physical activities.
  • 25% of respondents believe their families are ashamed of their diagnosis.
  • Those who said their families did not fully support them did a significantly poorer job of managing their diabetes than those who said they had their family's support.

HealthEngage Research Platform

The survey is the first conducted using HealthEngage's new online research platform, which allows surveys of its 150,000+ diabetics in 176 countries to be conducted in minutes or hours instead of days or weeks. It also provides a unique real-time visualization dashboard of key metrics (including demographic data, medication usage, glucose and other test averages, food, exercise, insulins, and over 30 other data types), which can be used to dig deeper into the data and spot trends and opportunities like never before.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,701.85 +23.62 0.13%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs